Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG: Placebo 0.04 mL twice daily
- DRUG: Placebo 0.04 mL once daily
- DRUG: Placebo 0.08 mL once daily
- DRUG: B - Exenatide 10 mcg twice daily
- DRUG: C - Exenatide 10 mcg once daily
- DRUG: Exenatide 20 mcg once daily
Sponsor
AstraZeneca
Collaborators